Clinical Trials

50 trials registered for Angelman Syndrome

Efficacy and Safety of Circadin® in the Treatment of Sleep Disturbances in Children With Neurodevelopment Disabilities
NCT01906866Phase 3Neurim Pharmaceuticals Ltd.
Completed
Genomic Imprinting and Assisted Reproductive Technologies
NCT00773825N/AAssistance Publique - Hôpitaux de Paris
Completed
Italian Angelman Syndrome Registry
NCT03650569N/AFROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
Completed
Minocycline in the Treatment of Angelman Syndrome
NCT01531582N/AUniversity of South Florida
Completed
Nutritional Formulation for Angelman Syndrome
NCT03644693N/AUniversity of Colorado, Denver
Completed
Single Dose Pharmacokinetic (PK) Study
NCT03109756Phase 1Healx AI
Completed
Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW
NCT02670694N/ABaylor College of Medicine
Completed
SNP-based Microdeletion and Aneuploidy RegisTry (SMART)
NCT02381457N/ANatera, Inc.
Completed
Study of Phenotype and Genotype Correlations in Patients With Contiguous Gene Deletion Syndromes
NCT00004351N/ANational Institute of Neurological Disorders and Stroke (NINDS)
Completed
Study on Tolerability of Levodopa/Carbidopa in Children With Angelman Syndrome
NCT00829439Phase 1Boston Children's Hospital
Completed
Study to Evaluate the Efficacy and Safety of Minocycline in Angelman Syndrome
NCT02056665Phase 2Puerta de Hierro University Hospital
Completed
Early Check: Expanded Screening in Newborns
NCT03655223N/ARTI International
Enrolling
Long-term Extension of GTX-102 in Angelman Syndrome
NCT06415344Phase 3Ultragenyx Pharmaceutical Inc
Enrolling
Parent and Infant Inter(X)Action Intervention (PIXI)
NCT03836300N/ARTI International
Enrolling
A Natural History Study of Angelman Syndrome
NCT07417137N/AMassachusetts General Hospital
Recruiting
A Phase 1/2 Study of the Safety and Efficacy of MVX-220 in Angelman Syndrome
NCT07181837Phase 1/2MavriX Bio, LLC
Recruiting
A Safety and Efficacy Study of GTX-102 in Subjects With Deletion- or Nondeletion-type Angelman Syndrome (AS)
NCT07157254Phase 2Ultragenyx Pharmaceutical Inc
Recruiting
Angelman Natural History Study - FAST Spain
NCT06115109N/APuerta de Hierro University Hospital
Recruiting
Angelman Syndrome Natural History Study
NCT04507997N/ABoston Children's Hospital
Recruiting
IDMet (RaDiCo Cohort) (RaDiCo-IDMet)
NCT05945576N/AInstitut National de la Santé Et de la Recherche Médicale, France
Recruiting
Load more